Pre-Conference - Wednesday, 18 September 2019
Meeting category
Date(s)
19 Sep 2019 - 20 Sep 2019
Location
Vilnius,
Lithuania
Meeting type
Live Meeting
Organizer
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Related Enduring Materials
Enduring Materials
Downloads:
Program
Day 1 - Thursday, 19 September 2019
Session 1: Epidemiology of HIV and hepatitis in the CEE countries - 09:00
Anca Streinu-Cercel, MD, PhD
09:00 CEST
Epidemiology of Viral Hepatitis Infection and Treatment in CEE Countries
09:30 CEST
Epidemiology of HIV Infection and Treatment in CEE Countries
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
10:00 CEST
Feasibility and Acceptability of HCV Self-Testing
Session 2: Access to Care - 11:00
11:00 CEST
EECA: Are we Lagging Behind?
11:10 CEST
Access to Quality Assured (WHO Prequalified) Generic Medicines in the Region
11:20 CEST
Access to Key Populations
11:30 CEST
Round Table Discussion
Session 3: HIV and Hepatitis Co-Infection - 11:45
11:45 CEST
Management of HIV/HCV Co-Infection in Young Women
12:00 CEST
Door-to-Door Hepatitis C Testing in Three Large Cities of Georgia: A Pilot Study
Maia Butsashvili
Georgia
12:10 CEST
The Prevalence of Mutations of the Hepatitis C Virus, Associated with Drug Resistance to Inhibitors of Protein NS5A Among Patients of the Republic of Belarus
12:20 CEST
Discussion
13:30 CEST
Industry-Sponsored Symposium
Session 4: PrEP - 14:30
14:30 CEST
PrEP and STI Testing in CEE: What are the Barriers, What Works?
15:00 CEST
Persistence on HIV Pre-Exposure Prophylaxis Medication: A Challenge in Pre-Exposure Prophylaxis (PrEP) Program in Georgia
Ekaterine Karkashadze
Georgia
15:10 CEST
Virological Efficacy of First-line Regimens, Resistance Profile and Factors Influencing Adherence to ART in Clinical Practice in Ukraine
15:20 CEST
Discussion
16:00 CEST
Industry-Sponsored Symposium
Session 5: Linkage to Care and Management of Treatment Failure in HIV - 17:00
17:00 CEST
Switching to Second Line HIV Therapy
18:00 CEST
Discussion
18:15 CEST
End of Day 1
Day 2 - Friday, 20 September 2019
Session 6: HIV and Tuberculosis Co-Infection - 09:00
09:00 CEST
Management of TB and HIV Infection
09:30 CEST
The Challenging TB Case: Clinical, Virological and Pharmacological Considerations
09:50 CEST
Discussion
10:00 CEST
Epidemiology of HIV in the Baltic Countries (Estonia, Latvia, Lithuania)
10:10 CEST
Uptake and Outcomes of Dolutegravir Based Antiretroviral Therapy in Georgia
Nino Rukhadze
Georgia
10:20 CEST
The New Tendencies in HIV and HCV Epidemics in Central Region of Ukraine
Session 7: Abstract-Driven Presentations - 11:00
11:00 CEST
Management of Hepatitis C in Primary Healthcare in the Country of Georgia
11:10 CEST
HCV Prevalence and Associated Factors Among People who Inject Drugs (PWID): Baseline Results of Georgian PWID Cohort Study
11:20 CEST
Diversity of HIV-1 Subtypes in Russia 2009-2019
11:30 CEST
Outcomes for Hepatitis B Vaccination among HIV-Infected Adults in Georgia
11:40 CEST
Epidemiology of Hepatitis B Viral Infection in the Republic of Belarus
11:50 CEST
Implementation of the State Program on Elimination of Viral Hepatitis C in Ukraine: Achievements and Challenges
12:00 CEST
High Level of Integrase Strand Transfer Inhibitors Drug Resistance Mutations in INSTIs Failed HIV-1 CRF06_cpx Infected Patients in Estonia
Session 8: Hot Topics in HIV and Hepatitis - 13:00
13:00 CEST
Treatment of Hepatitis B in Ukraine: What are the Remaining Challenges?
13:25 CEST
Vaccinations for HIV Patients: Which Vaccinations When and How?
13:50 CEST
HIV/HCV Co-Infection: Influence on Risk for Cancer and Cardiovascular Events, and Impact of Successful HCV Cure
14:15 CEST
The Acute HCV Epidemic in MSM: What did we Learn so far?
14:40 CEST
Closing Remarks
Satellite Symposia
Satellite Symposia
Day 1 - Thursday, 19 September 2019
Achieve HCV elimination: how to address regional challenges with real-world examples (Gilead) - 13:30
13:30
Welcome and introduction by chair
Mojca Maticic, MD, PhD
University of Ljubljana, Slovenia
13:40
Epidemiology of HIV infection and treatment in CEE countries
What are the challenges associated with HCV elimination in the region?
Marieta Simonova
Bulgaria
What practical strategies can be implemented for HCV elimination within the region?
Anca Streinu-Cercel
Romania
What are the critical steps in elimination strategies?
Stefano Fagiuoli
Italy
14:25
Closure of symposium by the chair
Mojca Maticic, MD, PhD
University of Ljubljana, Slovenia
AHCV Elimination: Simplifying Screening, Diagnosis and Treatment (Abbvie) - 16:00
16:00
HCV Elimination: Simplifying Screening and Diagnosis
HCV Elimination: Simplifying Screening and Diagnosis
Juozas Kupčinskas, Lithuania
16:30
Simplification of treatment: Role of Glecaprevir/ Pibrentasvir
Jean Michel Pawlotsky
France
Overview
Welcome
Over 200 participants attended the 5th edition of the Central and Eastern European Meeting on Viral Hepatitis and HIV, which took place from 19-20 September 2019 at the Radisson Blu Hotel Lietuva in Vilnius, Lithuania. The Organizing Committee would like to thank all the invited speakers and participants for their contribution to this meeting!
We are grateful to our supporters ViiV Healthcare, Gilead Sciences, Abbvie and MSD for making this event possible.
The Central and Eastern European Meeting on Viral Hepatitis and HIV is an independent program, initiated in 2014 and developed by regional and international key opinion leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries.
Program Chairs
Practical Information
Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the program and post-meeting survey.
Language
The official language of the meeting was English.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the meeting is finished, provided the speaker has given permission to do so.
Committees
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
- Viktor Aster, MD, PhD - Charles University, Czech Republic
- Inga Ažiņa, MD, PhD - Rīga Stradiņš University, Latvia
- Marine Gogia, MD - Georgian Harm Reduction Network, Georgia
- Andrzej Horban, MD, PhD - Hospital for Infectious Diseases, Poland
- David Jilich, MD - HIV Centre Prague, Czech Republic
- Natalia Matsieuskaya, MD, PhD - Grodno State Medical University, Belarus
- Cristina Popescu, MD, PhD - Carol Davila University of Medicine and Pharmacy, Romania
- Baiba Rozentāle, MD, PhD, MBA - Rīga Stradiņš University, Latvia
- Kristi Rüütel, MD, PhD - Scientific Institute for Health Development, Estonia
- Dalibor Sedláček, MD, PhD - University Hospital Plzen, Czech Republic
Support
Endorsers
Language
Related Programs
